|
|
|
|
|
|
|
|
|
|
Watch Drug Delivery Leader Live on 9/17/26 to explore how digitally connected autoinjectors, wearable injectors, and other self-administered drug delivery technologies are transforming patient care. Industry experts will discuss digital monitoring, adherence, dosing accuracy, regulatory expectations, and product development strategies that improve outcomes while supporting decentralized care. Discover the technical, business, and regulatory considerations shaping the future of connected drug delivery. Register free today!
|
|
|
|
|
|
|
|
By Fran DeGrazio, Drug Delivery Leader
|
In this article, Fran DeGrazio discusses the FDA draft guidance on Container Closure Systems in the context of risk-based product development for combination products and other injectable delivery systems.
|
|
|
|
|
|
Cross-Functional Decisions In Autoinjector Development
|
|
By Tom von Gunden, Chief Editor, Drug Delivery Leader
|
Videocast guest expert Aaron Mann, Windgap Medical's CEO, discusses product development decision points around delivering complex molecules via autoinjectors. Cross-functional considerations include high viscosity formulations, product stability, patient safety, and human factors.
|
|
|
|
|
|
|
|
What’s Slowing Nanomedicine Adoption In Drug Delivery?
|
|
Article | By Bob Moyer, Battelle
|
NAM adoption is constrained by inconsistent cell sourcing, limited standardization, and regulatory uncertainty — barriers that must be addressed to enable reproducible evidence and regulatory trust.
|
|
|
|
|
|
|
|
Next-Generation Packaging Solutions For Modern Drug Delivery
|
|
Article | By Scott Mills and Armando Pedoto, Adare Pharma Solutions
|
Pharmaceutical packaging must evolve alongside drug development to ensure stability, safety, and regulatory adherence, utilizing innovative designs to improve therapeutic outcomes and accessibility.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
.png){kind=logo}
